Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Rev. bras. oftalmol ; 74(4): 254-256, Jul-Aug/2015. graf
Article in Portuguese | LILACS | ID: lil-752077

ABSTRACT

Descrevemos um caso de perda visual irreversível bilateral em uma paciente de 64 anos após uso prolongado de paclitaxel. Ao exame oftalmológico paciente apresentou acuidade visual (AV) de 20/400 em ambos os olhos (AO) na primeira consulta. À tomografia de coerência óptica (TCO) evidenciou espessamento macular AO. Após seis meses da suspensão do paclitaxel, a paciente apresentava melhora discreta da AV atingindo 20/200 com correção em AO, além da TCO demonstrando resolução do espessamento retiniano.


We describe a case of bilateral irreversible visual loss of a 64 year-old patient after prolonged use of paclitaxel. Patient presented best corrected visual acuity of 20/400 in both eyes at first visit and optical coherence tomography showed increased macular in both eyes.After six months of the interruption of -paclitaxel therapy, the patient showed slight improvement of visual acuity reaching 20/200 in both eyes, while OCT demonstrated resolution of macular edema.


Subject(s)
Humans , Female , Middle Aged , Visual Acuity , Antineoplastic Agents, Phytogenic/adverse effects , Antineoplastic Agents, Phytogenic/toxicity , Macular Edema/chemically induced , Paclitaxel/adverse effects , Paclitaxel/toxicity
2.
Pakistan Journal of Pharmaceutical Sciences. 2013; 26 (5): 881-892
in English | IMEMR | ID: emr-138405

ABSTRACT

Cancer chemotherapy is an important strategy to treat this leading cause of death worldwide and plants may constitute a source of new antineoplastic agents. This work fractionated the ethanolic extract of Jacaranda puberula leaves and studied the in vitro antitumoral action and some toxicological effects of the most bioactive fraction. Cell lines related to worldwide cancers were used. The Dichloromethane [DCM] and PP fractions were the most bioactive ones. The anti-tumoral action of the DCM fraction was higher than that of the crude EtOH extract while that of PP fraction was higher than the original one [DCM] for both breast [MCF-7], prostate [PC3] and lung [A549] tumor cells, chronic leukemia cells. The K562 cells were the most sensitive cell line. The PP fraction [20 micro g/ml] cytotoxicity for these cells was similar to that of the ursolic acid triterpene or the antineoplastic ethoposide. The PP fraction inhibited K562 cell proliferation without cell cycle arrest in a specific phase or apoptosis. PP increased the mitochondrial reduction activity of lymphocytes. After a single dose by oral route, PP fraction did not induce intrinsic acute toxicity or animal death. This work demonstrated that the J. puberula fraction [PP] present high in vitro anti-tumoral effect with no cytotoxicity for immune system cells or oral acute toxicity, improving the Jacaranda puberula ethnopharmacology and reporting new biological effects for the genus Jacaranda


Subject(s)
Humans , Animals , Male , Female , Antineoplastic Agents, Phytogenic/pharmacology , Antineoplastic Agents, Phytogenic/toxicity , Cell Proliferation/drug effects , Cell Survival/drug effects , Ethanol/chemistry , Administration, Oral , MCF-7 Cells , K562 Cells , Mice , Neoplasms/pathology , Phytotherapy , Plant Leaves , Plants, Medicinal , Solvents/chemistry
3.
Article in English | IMSEAR | ID: sea-38997

ABSTRACT

BACKGROUND: Paclitaxel, an anti-neoplastic agent effective against several solid tumors, has several side effects including peripheral neuropathy. So far, there are no effective treatments for this complication. Monosialic acid ganglioside (GM1) has been shown to protect neurons against injuries and degeneration. However, its efficacy in the treatment of paclitaxel-induced neuropathy has not been verified. OBJECTIVE: To evaluate the effect of porcine GM1 on neurophysiological abnormalities in rats receiving paclitaxel. MATERIAL AND METHOD: Fifty-four Wistar rats were divided into control, vehicle for paclitaxel (Cremophor EL), paclitaxel, and paclitaxel + GM1 groups. Paclitaxel 16 mg/kg/week for five consecutive weeks was given intraperitoneally. Treatment with 30 mg/kg 5 days per week of GM1 was started 3 days prior to the first dose and continued until 3 days after the last dose of paclitaxel. Tail and hind paw thermal thresholds including tail motor nerve conduction velocity (MNCV) were measured prior to and after the start of treatments. Histopathology of the sciatic nerve was also examined. RESULTS: Paclitaxel alone induced thermal hypoalgesia and reduced tail MNCV Less severe abnormalities were also found with the vehicle. GM1 appeared to prevent the development of hypoalgesia and ameliorated the decreased MNCV without any evidence of Guillain-Barre Syndrome. Mild endoneurial edema and axonal degeneration in the sciatic nerve sections were seen in paclitaxel treated rats. Microtubule accumulation and activated Schwann cell were also presented in the paclitaxel treated groups. CONCLUSION: These data suggest that porcine GM1 may be useful in the prevention and treatment of paclitaxel-induced neuropathy. However the adverse effect of Cremophor EL should be of concern.


Subject(s)
Animals , Antineoplastic Agents, Phytogenic/toxicity , Dose-Response Relationship, Drug , G(M1) Ganglioside/adverse effects , Neurotoxicity Syndromes/drug therapy , Paclitaxel/toxicity , Peripheral Nervous System Diseases/chemically induced , Rats , Rats, Wistar , Sensation/drug effects
4.
Braz. j. med. biol. res ; 39(6): 801-807, June 2006. ilus, tab
Article in English | LILACS | ID: lil-428281

ABSTRACT

Piplartine {5,6-dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]-2(1H)pyridinone} and piperine {1-5-(1,3)-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]piperidine} are alkaloid amides isolated from Piper. Both have been reported to show cytotoxic activity towards several tumor cell lines. In the present study, the in vivo antitumor activity of these compounds was evaluated in 60 female Swiss mice (N = 10 per group) transplanted with Sarcoma 180. Histopathological and morphological analyses of the tumor and the organs, including liver, spleen, and kidney, were performed in order to evaluate the toxicological aspects of the treatment with these amides. Administration of piplartine or piperine (50 or 100 mg kg-1 day-1 intraperitoneally for 7 days starting 1 day after inoculation) inhibited solid tumor development in mice transplanted with Sarcoma 180 cells. The inhibition rates were 28.7 and 52.3 percent for piplartine and 55.1 and 56.8 percent for piperine, after 7 days of treatment, at the lower and higher doses, respectively. The antitumor activity of piplartine was related to inhibition of the tumor proliferation rate, as observed by reduction of Ki67 staining, a nuclear antigen associated with G1, S, G2, and M cell cycle phases, in tumors from treated animals. However, piperine did not inhibit cell proliferation as observed in Ki67 immunohistochemical analysis. Histopathological analysis of liver and kidney showed that both organs were reversibly affected by piplartine and piperine treatment, but in a different way. Piperine was more toxic to the liver, leading to ballooning degeneration of hepatocytes, accompanied by microvesicular steatosis in some areas, than piplartine which, in turn, was more toxic to the kidney, leading to discrete hydropic changes of the proximal tubular and glomerular epithelium and tubular hemorrhage in treated animals.


Subject(s)
Animals , Female , Mice , Alkaloids/therapeutic use , Antineoplastic Agents, Phytogenic/therapeutic use , Benzodioxoles/therapeutic use , Piper/chemistry , Piperidines/therapeutic use , Piperidones/therapeutic use , Polyunsaturated Alkamides/therapeutic use , /drug therapy , Alkaloids/isolation & purification , Alkaloids/toxicity , Antineoplastic Agents, Phytogenic/isolation & purification , Antineoplastic Agents, Phytogenic/toxicity , Benzodioxoles/isolation & purification , Benzodioxoles/toxicity , Cell Proliferation/drug effects , Disease Models, Animal , Kidney/drug effects , Kidney/pathology , Liver/drug effects , Liver/pathology , Neoplasm Transplantation , Piperidines/isolation & purification , Piperidines/toxicity , Piperidones/isolation & purification , Piperidones/toxicity , Plant Extracts/isolation & purification , Plant Extracts/therapeutic use , Plant Extracts/toxicity , Plant Roots/chemistry , Polyunsaturated Alkamides/isolation & purification , Polyunsaturated Alkamides/toxicity , /pathology , Spleen/drug effects , Spleen/pathology
5.
Indian J Physiol Pharmacol ; 2001 Apr; 45(2): 253-7
Article in English | IMSEAR | ID: sea-108011

ABSTRACT

The effect of aqueous extract of Withania somnifera (L. Solanaceae) was studied against paclitaxel induced neutropenia in mice. After paclitaxel 1 mg/kg, i.v. administration significant fall in total WBC and absolute neutrophil count was observed on day 3 and day 5. W. Somnifera (200 mg/kg, p.o.) per se produced significant increase in neutrophil counts. W. somnifera (200 mg/kg, p.o.) when administered for 4 days before paclitaxel treatment and continued for 12 days caused significant reversal of neutropenia of paclitaxel. The findings of the study suggest the potential of W. somnifera as an adjuvant during cancer chemotherapy for the prevention of bone marrow depression associated with anticancer drugs.


Subject(s)
Animals , Antineoplastic Agents, Phytogenic/toxicity , Granulocyte-Macrophage Colony-Stimulating Factor/therapeutic use , India , Male , Mice , Neutropenia/chemically induced , Paclitaxel/toxicity , Phytotherapy , Plant Extracts/therapeutic use , Plants, Medicinal
SELECTION OF CITATIONS
SEARCH DETAIL